The FDA has noted both the lack of human clinical trial data and uncertainty about long-term safety
Sikiric P, Jelovac N, Jelovac-Gjeldum A, Dodig G, Staresinic M, Anic T, et al
While preclinical data on the peptide BPC-157 reveals profound therapeutic potential, clinicians are left navigating a landscape where robust human trials are conspicuously absent
Peptides, or small protein fragments, are often too unstable to use as drugs, but in this study, the researchers also developed a way to stabilize the molecules and help them get into target cells
It upregulates the Anti-Inflammatory Gene Transcription Factor, and Growth Hormone receptors, all leading to better systemic repair response
It is certainly not sufficient for a GP practice just to say that it is their policy or internal procedure